CD274 and non-small cell lung carcinoma: Interestingly, a 2018 paper by Guibert and colleagues reported an increased frequency of PD-L1 positivity on CTCs in comparison to tissue samples (83% vs. 41%) in a population of advanced NSCLC (168).